Itonic Holdings vs Pulse Biosciences
Itonic Holdings is the larger business, with $523,031 of revenue in fiscal 2025 against $350,000 for Pulse Biosciences (1.5 times as much). Itonic Holdings kept more of each dollar of sales as profit: a net margin of -974.7% against -20794.6%.
| Latest fiscal year | Itonic HoldingsITOC, 2025 | Pulse BiosciencesPLSE, 2025 |
|---|---|---|
| Revenue | $523,031 | $350,000 |
| Revenue growth | 16.7% | — |
| Net income | −$5.1m | −$72.8m |
| Operating margin | -991.7% | — |
| Net margin | -974.7% | -20794.6% |
| Return on equity | -82.8% | -74.4% |
| Free cash flow | −$3.2m | −$54.4m |
| Cash | $1.5m | $80.7m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 116 |
| Market value | $34.6m | $3.66bn |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 8 buys, 7 sales |